Seven Fleet Capital Management LP
Position in ELVN — Enliven Therapeutics, Inc.
CIK 2092021
MOUNTAIN VIEW, CA
Position in ELVN
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$18,543,339
+$12,113,363 QoQ
Shares Held
365,386
+122.8% QoQ
Ownership
0.499%
of shares outstanding
% of Portfolio
3.04%
of 13F equity value
Holder Rank
#45
of 210 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 79%
Shared 21%
None 0%
Common Shares in ELVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Seven Fleet Capital Management LP holds $585,168,790 across 88 Biotechnology names. ELVN ranks #5 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGON |
CG Oncology, Inc.
|
1,886,236 | $134,017,067 | |
| 2 | TNGX |
Tango Therapeutics, Inc.
|
3,228,144 | $100,911,781 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
242,029 | $45,327,190 | |
| 4 | PHVS |
Pharvaris N.V.
|
774,501 | $26,782,243 | |
| 5 | ELVN |
Enliven Therapeutics, Inc.
This page
|
365,386 | $18,543,339 | |
| 6 | ABVX |
Abivax S.A.
|
111,334 | $14,836,368 | |
| 7 | AVTX |
Avalo Therapeutics, Inc.
|
770,765 | $14,243,736 | |
| 8 | MIRM |
Mirum Pharmaceuticals, Inc.
|
110,393 | $12,923,708 |
All Filings in ELVN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,543,339 | 365,386 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $6,429,976 | 164,030 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,539,276 | 99,953 | Shares | Sole | 2026-04-02 | |
| No filing history on record for this holder in this stock. | ||||||